Fennec Pharmaceuticals Inc (FENC)
NASDAQ
Quarter End | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 0 | 0 | 1.54M | 1.68M | 3.33M | 6.52M | 9.74M | 25.38M |
Operating Income | -5.01M | -7.9M | -6.28M | -5.27M | -4.67M | -1.02M | -1.82M | 13.74M |
Pre Tax Income | -5.07M | -8.09M | -6.86M | -6.05M | -5.44M | -1.87M | -2.68M | 12.84M |
Net Income | -5.07M | -8.09M | -6.86M | -6.05M | -5.44M | -1.87M | -2.68M | 12.84M |
Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Basic Earnings Per Share (EPS) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EBIT | -5.01M | -7.9M | -6.28M | -5.27M | -4.67M | -1.02M | -1.82M | 13.74M |
EBITDA | -5.01M | -7.9M | -6.28M | -5.27M | -4.67M | -1.02M | -1.82M | 13.74M |
Year End December 30 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 0 | 0 | 0 | 0 | 170k | 0 | 1.54M | 21.25M |
Operating Income | -2.87M | -6.95M | -10.41M | -13.01M | -17.89M | -17.22M | -22.74M | -12.77M |
Pre Tax Income | -2.79M | -7.05M | -9.89M | -12.78M | -18.11M | -17.35M | -23.71M | -16.05M |
Net Income | -2.79M | -7.05M | -9.89M | -12.78M | -18.11M | -17.35M | -23.71M | -16.05M |
Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Basic Earnings Per Share (EPS) | -0.204 | -0.383 | -0.497 | -0.642 | -0.696 | -0.667 | -0.9 | -0.594 |
EBIT | -2.85M | -6.96M | -10.4M | -13.03M | -17.89M | -17.22M | -22.74M | -12.77M |
EBITDA | -2.87M | -6.95M | -10.41M | -13.01M | -17.89M | -17.22M | -22.74M | -12.77M |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.